These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12151559)

  • 21. Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-parkinsonian rats.
    Poulton NP; Muir GD
    Exp Neurol; 2005 May; 193(1):181-97. PubMed ID: 15817277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease.
    Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB
    Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys.
    Eslamboli A; Baker HF; Ridley RM; Annett LE
    Exp Neurol; 2003 Oct; 183(2):418-29. PubMed ID: 14552882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
    Ariano MA; Grissell AE; Littlejohn FC; Buchanan TM; Elsworth JD; Collier TJ; Steece-Collier K
    J Neurosci Res; 2005 Nov; 82(3):387-96. PubMed ID: 16180225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
    Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB
    J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease.
    Metz GA; Piecharka DM; Kleim JA; Whishaw IQ
    Brain Res; 2004 Nov; 1026(1):126-35. PubMed ID: 15476704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts.
    Rödter A; Winkler C; Samii M; Nikkhah G
    Cell Transplant; 2000; 9(2):197-214. PubMed ID: 10811393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.
    Howells FM; Russell VA; Mabandla MV; Kellaway LA
    Behav Brain Res; 2005 Dec; 165(2):210-20. PubMed ID: 16159673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
    Pinna A; Tronci E; Schintu N; Simola N; Volpini R; Pontis S; Cristalli G; Morelli M
    Neuropharmacology; 2010 Mar; 58(3):613-23. PubMed ID: 19951715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion.
    McGrath J; Lintz E; Hoffer BJ; Gerhardt GA; Quintero EM; Granholm AC
    Cell Transplant; 2002; 11(3):215-27. PubMed ID: 12075987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat.
    Barc S; Page G; Barrier L; Garreau L; Guilloteau D; Fauconneau B; Chalon S
    J Neurochem; 2002 Feb; 80(3):365-74. PubMed ID: 11905985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats.
    Palmer MR; Granholm AC; van Horne CG; Giardina KE; Freund RK; Moorhead JW; Gerhardt GA
    Brain Res; 2001 Jan; 890(1):86-99. PubMed ID: 11164771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.
    Simola N; Di Chiara G; Daniels WM; Schallert T; Morelli M
    Neuroscience; 2009 Feb; 158(4):1625-31. PubMed ID: 19063947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat.
    Cintra A; Aguirre JA; Andbjer B; Finnman UB; Hagman M; Agnati LF; Höglund C; Möller A; Fuxe K
    Neurosci Lett; 1999 Oct; 274(1):5-8. PubMed ID: 10530506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
    Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
    Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.